Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in locally advanced or metastatic epithelial tumors

  1. Juric, D.
  2. Dienstmann, R.
  3. Cervantes, A.
  4. Hidalgo, M.
  5. Messersmith, W.
  6. Blumenschein, G.R.
  7. Tabernero, J.
  8. Roda, D.
  9. Calles, A.
  10. Jimeno, A.
  11. Wang, X.
  12. Bohorquez, S.S.
  13. Leddy, C.
  14. Littman, C.
  15. Kapp, A.V.
  16. Shames, D.S.
  17. Penuel, E.
  18. Amler, L.C.
  19. Pirzkall, A.
  20. Baselga, J.
Aldizkaria:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Argitalpen urtea: 2015

Alea: 21

Zenbakia: 11

Orrialdeak: 2462-2470

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-14-2412 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus